Therapeutic Interventions- Potential of Phytochemicals against Coronavirus-Associated Pulmonary Disease

In the meantime, the epidemic of the Covid-19 virus (COVID-19) in December 2019, cases of infection and death rates are constantly increasing. So far, no effective treatment for Covid Covid-19 has been identified, so thus efforts are being made to search for a treatment extracted from natural sources such as plants to reduce the side effects of chemical drugs. A lung infection as a result of a severe and intensive respiratory disease called Covid-2 is one of the consequences produced by infection with the Covid-19 virus (SARS-CoV-2). Similarly, data from throughout the world shows that these phytochemicals have antiviral effects, comprising anti-SARS-CoV activity that might clear the ways by providing appropriate combinations suitable for Coronavirus therapy. In the current investigation, the applicant's phytochemicals and associated activity components emerged in the treatment/insurance of lung wounds caused by various techniques. Regarding the pharmacological component, phytochemicals have demonstrated possible inhibitory impacts on inflammatory and oxidative pathways, associated with the pathogenesis of lung damage during Coronavirus disease. This review highlighted a brief summary of phytochemicals that shows potential against SARS-CoV-2 and associated pulmonary diseases